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Abstract
Background: Between 7% and 48% of cancer patients report taking herbal medicines after
diagnosis. Because of the possibility of unwanted side effects or interactions with conventional
treatments, people with cancer are generally advised to tell the professionals treating them if they
are taking any form of medication, including herbal medicines and supplements. Studies suggest that
only about half do so and that the professionals themselves have at best very limited knowledge
and feel unable to give informed advice. This study is intended to inform the future development
of information resources for cancer patients, survivors and healthcare professionals including tools
for use before or during consultation to make it easier for patients to mention, and for healthcare
professionals to ask about, use of herbal medications.
Methods/design: This is a three-phase study. In phase 1, a systematic review of the literature on
self-medication with herbal medicines among UK populations living with cancer will establish the
current evidence base on use of herbal medicine, sources of information, characteristics and
motivations. This will allow us to better understand what aspects need further investigation and
inform the topic guide for a qualitative study (phase 2). Six focus groups of six to eight cancer
patients who have used at least one herbal preparation since diagnosis will explore behaviour,
beliefs, knowledge, information sources and needs in an informal conversational setting.
Informed by the findings of the systematic review and qualitative study, in phase 3 we will construct
and pilot a questionnaire for a future large-scale survey to quantify and prioritise people's beliefs,
needs and information preferences.
Discussion:  Despite known interactions with conventional cancer treatments and
contraindications for some herbal remedies with specific cancers, reliable information resources
for patients are very limited. Identifying cancer patients' information needs and preferences is the
first step in creating a suitable resource for both the public and the professionals advising them.
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Background
Self-medication with herbal remedies and 'natural' medi-
cations taken by mouth is widespread and growing in the
UK [1]. Almost half of women with breast cancer report
taking herbal remedies, vitamins, or other supplements
during treatment [2]. Among cancer patients in general,
7% report taking herbal medicines [3]. Self-medication
may be used to help counteract the effects of cancer treat-
ment; to alleviate symptoms of cancer; to boost the
immune system; to deal with another condition; or in the
hope of tackling the cancer itself [2,4,5]. It may also pro-
vide a sense of control or of being actively involved in
treatment [3,5]. However, some herbal medicines may
cause problems unrelated to cancer; black cohosh, used
by women taking hormonal medications after breast can-
cer, is associated in rare cases with serious liver problems
[6]. This herb is also contra-indicated for women with
oestrogen-receptor positive breast cancer because of
uncertainty about possible oestrogenic activity, as are
Dong Quai and ginseng which have been shown to stim-
ulate cell growth in a human breast cancer cell line. [7].
Herbal remedies can also interfere with conventional
treatments. St John's Wort can speed up the time that the
body takes to get rid of the anti-cancer treatment, Imatinib
by 44% [8]. People nevertheless tend to believe that 'nat-
ural' remedies are harmless [3,5]. A study of patients on
warfarin indicated that only 28% of those also taking
herbal medicines believed that these could interact with
conventional drugs [9].
Because of the possibility of unwanted side effects or
interactions, people with cancer are generally advised to
tell the professionals treating them if they are taking any
form of medication, including herbal medicines and sup-
plements [10]. Studies suggest that only about half of
them do so [3,10] and that healthcare professionals them-
selves may be unable to give informed advice. A survey of
anaesthetists in the UK revealed that although 65% felt
that herbal medicines might sometimes have potentially
harmful effects in people undergoing surgery, 82% felt
that their own knowledge of herbal remedies was inade-
quate [11]. There is evidence that the most common
sources of advice on herbal medications are friends and
relatives or support and self-help groups [12].
There is no authoritative, readily accessible and independ-
ent source of information in the UK about herbal reme-
dies and other supplements where people can find out
about possible adverse (or beneficial) effects or interac-
tions with their prescribed medicines. The NHS Direct
website [13] offers superficial information on a limited
number of conditions such as eczema and migraine, but
fails to mention herbal remedies either in relation to can-
cer or to possible adverse effects or interactions with con-
ventional drugs. Cancerbackup [14] offers a general
warning that 'Some herbal medicines may contain substances
that could be harmful to some people with cancer, such as
arsenic, steroids or oestrogen' with some advice in relation to
specific herbs and Traditional Chinese Medicine (TCM)
under Frequently Asked Questions. Cancer Research UK's
CancerHelp website advises 'Do let your doctor know about
any herbal remedies you are thinking of taking, or are already
using' [15]. The Medicines and Healthcare Products Regu-
latory Agency (MHRA) [16] is developing a series of
patient information pages based on approved patient
information leaflets from registered herbal medicines, but
at present there are only ten such leaflets, and the site is
not likely to be a natural port of call for cancer patients
seeking information, nor is it specifically designed for
them. By contrast, many herbal medicine retailers have a
web presence and are actively advocating the use of a
range of herbal treatments for cancer. Work among breast
and prostate cancer patients does show that very few
patients trust the Internet as a source of information or
support, whether biomedical or non-biomedical [17].
Patients are concerned about not being able to judge the
qualifications of the people making claims and thus being
unable to judge the truth of the claims of those trying to
promote Complementary and Alternative Medicine
(CAM) or biomedicine [18]. Accessible, interpretable and
reliable information materials regarding herbal medicines
need to be developed.
This study will explore what people living with cancer
believe about, and hope to achieve by, self-medication
with herbal remedies; how far they are aware of the poten-
tial for harm in herbal self-medication; where they obtain
information on herbal remedies they use to support their
cancer treatment; if they seek help from healthcare profes-
sionals about herbal medicines, and, if so, why and from
whom; what response and advice they receive; what kinds
of information they would like, and how this could best
be provided. By understanding the beliefs and motiva-
tions involved, this study will assist the development of
educational materials for both patients and professionals
including a herbal medications information sheet for use
in routine clinical visits to encourage both disclosure by
patients and questioning by healthcare professionals. It
will also provide the necessary understanding and back-
ground for a subsequent quantitative study that will iden-
tify the most commonly used herbal preparations and
help to prioritise information needs and appropriate ways
of meeting them.
Methods/Design
This is a three-phase study incorporating a systematic
review of the literature (phase 1), a qualitative study
(phase 2) and the development and piloting of a ques-
tionnaire (phase 3) which will form the basis of a future
survey. See figure 1. Study design.BMC Complementary and Alternative Medicine 2009, 9:14 http://www.biomedcentral.com/1472-6882/9/14
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Study design Figure 1
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Phase 1: Literature review
A narrative systematic review of the literature on self-med-
ication with herbal medicines and supplements among
people living with cancer in the UK will be undertaken to
establish what is known about how many use herbal rem-
edies, what they take, their characteristics, motivations
and information needs and sources. This will allow us to
better understand where further investigation is required.
A scoping search of the literature suggests that research in
this area is limited. The review will be confined to studies
based on UK populations because practices and beliefs
about herbal remedies may be very different in other
countries. In Germany, for instance, 50% of phytomedic-
inal products are sold on medical prescription, the cost
being refunded by health insurance [19]. In the UK,
herbal medicine is seen as outside mainstream medical
practice [1]. Both China and India have highly developed
systems of traditional medicine based largely on herbs,
and the beliefs and principles underlying these, (as well as
the types of herbal remedies used), are very different from
the biomedical model prevalent in the UK [20].
European Directive 2004/24/EC [21] defines a herbal
medicinal product as 'any medicinal product, exclusively
containing as active ingredients one or more herbal sub-
stances or one or more herbal preparations, or one or
more such herbal substances in combination with one or
more such herbal preparations'. A herbal substance is
defined as 'whole, fragmented or cut plants, plant parts,
algae, fungi, lichen in an unprocessed, usually dried,
form, but sometimes fresh and herbal preparations'.
Herbal preparations are defined as 'preparations obtained
by subjecting herbal substances to treatments such as
extraction, distillation, expression, fractionation, purifica-
tion, concentration or fermentation'.
For the purposes of the literature review, herbal remedies
will be defined as medicines conforming to the European
definition above and taken for the treatment or preven-
tion of signs and symptoms of disease or ill-health, or the
maintenance of well-being. Herbal remedies made from
more than one plant will be included, as will ginger, garlic
and similar plant-derived substances if they are being used
for medicinal purposes and are being taken in the form of
supplements rather than as flavouring agents. Homeo-
pathic preparations, minerals, and vitamins will be
excluded. Electronic bibliographic databases (Medline,
PsycLIT CINAHL, EmBase, AMED, SIGLE, NLH and other
specialist databases) and web-based search strategies will
be used.
A minimum of two independent reviewers will screen
titles and abstracts for relevance. Disagreements will be
resolved by discussion or after retrieval and examination
of full papers. Data will be extracted by two reviewers
using predefined forms, and papers will be quality
assessed using a checklist. We anticipate that the variety of
study designs and outcomes will prohibit meta-analysis
and in this case synthesis will comprise a narrative review
of the participants, interventions and outcomes.
Phase 2: Qualitative study
Eligibility criteria
1. People who are at least six months and no more than
five years after diagnosis of invasive cancer, who are being
followed up at University Hospital, Birmingham NHS
Foundation Trust or University Hospitals Coventry and
Warwickshire Foundation Trust, and treated with curative
intent. Recruitment will be via a postal screening ques-
tionnaire (see below). Patients known to be terminally ill,
or whom the responsible consultant believes may be dis-
tressed by receipt of the questionnaire for any reason, will
be excluded to minimise the possibility of distress.
2. People who are at least six months and no more than
five years after diagnosis of invasive cancer, being fol-
lowed up at either of the two participating hospitals and
currently undergoing palliative treatment. Patient recruit-
ment will take place during follow-up visits. This popula-
tion will ensure that herbal remedy use to ameliorate the
side-effects of palliative treatments such as chemotherapy
and radiotherapy are included.
Recruitment
A screening questionnaire, letter of invitation and a
patient information sheet will be sent to 1,500 eligible
patients, 750 from each hospital site. The screening ques-
tionnaire will also be distributed, at follow-up appoint-
ments, to 200 patients who are known to be receiving
palliative care. The questionnaire will establish patients'
use of herbal medicines, socio-demographics, the nature
and stage of their cancer, and their willingness to partici-
pate in a focus group. It will allow us to broadly describe
the characteristics of users and provide information to
enable us to undertake stratified recruitment to the focus
groups.
In the unlikely event that insufficient participants for
focus groups are identified by the screening question-
naire, a poster describing the study (and distribution of
recruitment materials by research nurses at outpatient fol-
low-up clinics in the two participating centres (Birming-
ham and Coventry) will be used as a 'back-up' recruitment
strategy.
If any non-English-speaking patients express an interest in
participating, the appropriate NHS Trust will be
approached to provide an interpreter, and those patients
will be interviewed individually.BMC Complementary and Alternative Medicine 2009, 9:14 http://www.biomedcentral.com/1472-6882/9/14
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Invitations to focus groups
Patients returning a completed screening questionnaire,
having used at least one herbal medicine or supplement
since diagnosis, and expressing an interest in further par-
ticipation will be eligible to be invited to participate in a
focus group. Invitees will be those who have either almost
finished treatment, or have completed it recently enough
to be able to remember what medications (herbal and
conventional) they took.
Recruitment of 200 patients undergoing palliative care
will enable differences between this population and the
curatively treated group that form the basis of the survey
to be identified. Should significant demographic or can-
cer-specific differences be found between those receiving
curative and palliative treatment, we will attempt to hold
a focus group of individuals from this sub-group.
Eligible patients will be contacted and arrangements
made for them to attend a focus group to discuss their
knowledge, behaviour, attitudes and beliefs in relation to
self-medication with herbal remedies. Our previous expe-
rience indicates that participants are often more forth-
coming in the presence of others of similar age, and we
will ensure as far as possible that men are adequately rep-
resented, although they tend to use herbal remedies less
often than women (77% women: 23% men)[22]. Where
possible, we will have separate focus groups for people
who are disease-free and who have progressive/longer
term stable disease, as mixing patients at different stages
of the disease may inhibit discussion. We will select par-
ticipants accordingly, and replace refusals with others
with similar characteristics. If some subsets of interest
(e.g. working age men) remain under-represented, we will
undertake mini-groups of 3–4 people, paired interviews
or provide the option of individual interviews for those
who want to contribute but cannot attend at the times
allocated.
Feasibility
The prevalence of herbal medicine use among cancer
patients has been estimated to be between 7% [3] and
13% [23]. Assuming a 60% response rate, a survey of
1,500 individuals would generate 900 responses; if 50%
agree to participate in a focus group (n = 450) the number
of respondents taking herbal medicines and thus eligible
for interview will be between 31 (7%) and 58 (13% esti-
mate). We would anticipate recruiting at least another ten
eligible respondents from each site via additional recruit-
ment activities (poster and distribution of materials by
nurses). Up to 60 people will be invited to attend for inter-
view. This will allow for six focus groups of six to eight
people, plus any individual interviews as required to
replace drop-outs and include people who may not be
able to attend a group.
Power calculations
Assuming that the prevalence of herbal medicine use
among cancer patients is between 7% [3] and 13% [23]
and a 60% response rate, a survey of 1,500 individuals
would generate 900 responses. This sample would be of
sufficient size to determine the overall prevalence of
herbal medicine use amongst respondents with a preci-
sion of 2% (95% confidence).
Methods
Content and conduct of focus groups
Focus groups are an effective way of exploring the views of
people with a common background [24] as they allow
interaction and discussion between participants. The
focus group topic guide will be informed by existing liter-
ature and will cover a range of themes:
￿ use of herbal medication before and after cancer
diagnosis
￿ reasons for use of herbal remedies (e.g. 'boost
immune system', counteract effects of treatment)
￿ beliefs about the nature, properties and effects of
herbal remedies
￿ whether use of herbal remedies was/is disclosed to
healthcare professionals
￿ reasons for non-disclosure
￿ sources of advice (formal, informal, professional,
commercial)
￿ role of healthcare professionals in providing advice
on herbal medicine
￿ what advice was received/acted upon
￿ awareness/knowledge of and/or beliefs about possi-
ble side-effects and interactions with conventional
medicines or effects on cancer itself
￿ changes in behaviour and beliefs as the patient jour-
ney progresses.
The topic guide will be structured around these themes,
but with flexibility to explore any relevant issues that
emerge from individual focus groups.
Experienced qualitative researchers will conduct the focus
groups, with one researcher facilitating the group, and
another observing and taking detailed field notes. The ses-
sions will last one and a half to two hours, and will beBMC Complementary and Alternative Medicine 2009, 9:14 http://www.biomedcentral.com/1472-6882/9/14
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recorded and fully transcribed. The groups will be held in
locations convenient for participants.
Analysis
Each transcript will be independently analysed by two
experienced qualitative researchers, using the principles of
thematic content analysis [25]. This involves reading the
transcripts and identifying emerging themes and catego-
ries, with attention to the interaction between partici-
pants. Additionally, the co-applicants from different
disciplines and two lay collaborators will read and analyse
some of the (anonymised) transcripts in order to establish
consensus about the key themes arising from the focus
groups. These agreed themes will then be compared in
order to detect similarities within, and differences
between, groups. The emerging themes will be used to
inform the design of the quantitative questionnaire for
phase 3.
Phase 3: Development of quantitative questionnaire
A questionnaire to quantify and prioritise people's beliefs,
needs and preferences, suitable for both paper and elec-
tronic completion, will be developed based on the find-
ings of the systematic review, the recruitment
questionnaire and the qualitative study. It will be piloted
on paper in ten face- to-face interviews conducted by the
lay researchers, who will sit with respondents as they com-
plete the questionnaire and identify omissions, problems
of understanding and design issues. Members of the
National Cancer Research Institute's Consumer Liaison
Group (NCRI CLG) will also be asked to pilot the ques-
tionnaire online and to comment on its construction and
content. The revised questionnaire will be re-tested with
five face-to-face interviews.
Ethical approval
This study has been approved by the Birmingham, East,
North and Solihull Research Ethics Committee (REC),
[Ref 08/H1206/153].
Discussion
Most research into cancer patients' use of, and attitudes to,
herbal medicines in the UK is carried out in the context of
CAM generally. It is difficult to unravel the beliefs and
information needs about complementary and alternative
therapies with little potential for harm, such as reflexology
or homeopathy, from those about herbal remedies, which
have the potential both for harm and good. Some herbal
medications can be dangerous, both in their own right
and by interacting with cancer treatments. Despite this,
there is no information readily available about the herbal
remedies that people living with cancer use during and
after their treatment, nor on the beliefs, motivations,
knowledge and behaviour involved. Reliable information
resources for patients, especially in the UK, are very lim-
ited. This study will assist the development of easily acces-
sible educational materials for both patients and
professionals, help to establish the kinds of information
people would find useful, and indicate the most appropri-
ate ways of ensuring that they can find it easily. It will
inform the subsequent development of a quantitative sur-
vey that will help decision-makers prioritise both the
information needed and the best ways to deliver it for rel-
evance, ease of understanding and accessibility.
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